Concepedia

Michael A. DeBord

MA

Statistics

Publications

5

Citations

94

H-Index

5

Active since

2015

Affiliations

University of Akron(Current)

Michael A. DeBord is an author at University of Akron specializing in medicinal chemistry, pharmacy, and chemistry.

ORCID

Publications per year

2015–2018

5

Publications

5

Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines

Brian D. Wright, Michael C. Deblock, Patrick O. Wagers et al. · Medicinal Chemistry Research · 2015 · 36 citations

, , +6

Synthesis, anti-proliferative activity, SAR study, and preliminary in vivo toxicity study of substituted N,N′-bis(arylmethyl)benzimidazolium salts against a panel of non-small cell lung cancer cell lines

Kerri L. Shelton, Michael A. DeBord, Patrick O. Wagers et al. · Bioorganic & Medicinal Chemistry · 2016 · 23 citations · Full text

, , +8

Synthesis, anti-proliferative activity, and toxicity of C4(C5) substituted N,N′-bis(arylmethyl)imidazolium salts

Kerri L. Shelton, Michael A. DeBord, Patrick O. Wagers et al. · Tetrahedron · 2016 · 13 citations

, , +6

Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N′bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLC

Michael A. DeBord, Marie R. Southerland, Patrick O. Wagers et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 11 citations · Full text

, , +6

Synthesis and Characterization of Cobalt(II) <i>N</i>,<i>N</i>′-Diphenylazodioxide Complexes

Kylin A. Emhoff, Lakshmi Balaraman, Sydney Simpson et al. · ACS Omega · 2018 · 11 citations · Full text

, , +16

1–5 of 5